The historical overuse of the Swan-Ganz catheter highlights the importance of rigorously assessing the risk/benefit ratio of diagnostic and therapeutic modalities before widespread adoption.
Answers are grounded in this paper and cite their sources.
May prompt reduced SGC use in practice; leaves open targeted applications in select populations.
DOI: http://dx.doi.org/10.5915/40-2-4450 Since its introduction in 1970, the Swan-Ganz catheter (SGC) has been used extensively, particularly in critical care units. A recent well-designed randomized clinical trial confirmed earlier suspicions that the widespread use of the SGC caused more harm than good. This account of historical SGC use has some valuable lessons for all practitioners, who at times tend to embrace and overuse the ever-increasing diagnostic or therapeutic modalities without fully assessing the risk/benefit ratio.
No takes yet. Share an insight, caveat, or question.
Hakim et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: